, /PRNewswire/ -- 集体诉讼律师 Juan Monteverde 与 Monteverde &amp; Associates PC（“M&amp;A 集体诉讼事务所”）为股东追回了数百万美元，并在 2025 年 ISS 证券集体诉讼服务报告中被认定为 前 50 名 事务所。我们总部位于 帝国大厦，位于纽约市，并正在调查
<ul>
<li>VYNE Therapeutics Inc. (NASDAQ: VYNE ) 与 Yarrow Bioscience, Inc. 的合并。完成拟议交易后，VYNE 股东预计将拥有合并公司 3% 的股份。</li>
</ul>
点击此处获取更多信息 https://monteverdelaw.com/case/vyne-therapeutics-inc/ 。这是免费的，您无需支付任何费用或承担任何义务。
<ul>
<li>Masimo Corporation (NASDAQ: MASI ) 与 Danaher Corporation 的出售相关。根据拟议交易的条款，Masimo 股东将获得每股 180.00 美元的现金。</li>
</ul>
立即行动。股东投票定于 2026 年 5 月 1 日。
点击此处获取更多信息 https://monteverdelaw.com/case/masimo-corporation/ 。这是免费的，您无需支付任何费用或承担任何义务。
<ul>
<li>Independent Bank Corporation (NASDAQ: IBCP ) 与 HCB Financial Corp. 的出售相关。根据拟议交易的条款，HCB 股东预计将获得 1.5900 股 Independent 普通股和每股 HCB 普通股 17.51 美元。</li>
</ul>
点击此处获取更多信息 https://monteverdelaw.com/case/independent-bank-corporation/ 。这是免费的，您无需支付任何费用或承担任何义务。
<ul>
<li>HCB Financial Corp. (OTCPK: HCBN ) 与 Independent Bank Corporation 的合并相关。根据拟议交易的条款，HCB 股东预计将获得 1.5900 股 Independent 普通股和每股 HCB 普通股 17.51 美元。</li>
</ul>
点击此处获取更多信息 https://monteverdelaw.com/case/hcb-financial-corp/ 。 这是免费的，您无需支付任何费用或承担任何义务。
并非所有律师事务所都是一样的。 在您聘请律师事务所之前，您应该与律师交谈并询问：
<ol>
<li>您是否提起集体诉讼并出庭？</li>
<li>您上次为股东追回资金是什么时候？</li>
<li>您在哪些案件中追回了资金，金额是多少？</li>
</ol>
关于 Monteverde &amp; Associates PC
我们的事务所进行诉讼并为股东追回资金……我们在帝国大厦的办公室进行此项工作。我们是一家全国性的集体诉讼证券事务所，在审判和上诉法院，包括美国最高法院，拥有成功的业绩。
没有公司、董事或高管高于法律。 如果您拥有上述公司普通股并有疑虑或希望免费获取更多信息，请访问我们的 网站 或通过电子邮件联系 Juan Monteverde, Esq.，电子邮件地址为 [email protected] 或拨打电话 (212) 971-1341。
联系方式：
Juan Monteverde, Esq.
MONTEVERDE &amp; ASSOCIATES PC
帝国大厦
350 Fifth Ave. Suite 4740
New York, NY 10118
美国
[email protected]
电话: (212) 971-1341
律师广告。(C) 2026 Monteverde &amp; Associates PC。本广告的责任律师事务所为 Monteverde &amp; Associates PC (www.monteverdelaw.com)。之前的结果并不保证未来事务的类似结果。
来源 Monteverde &amp; Associates PC
<img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNDAxJk5ld3NJdGVtSWQ9REMyNTAwOCZUcmFuc21pc3Npb25fSWQ9MjAyNjA0MDExNDA2UFJfTkVXU19VU1BSX19fX19EQzI1MDA4?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNDAxJk5ld3NJdGVtSWQ9REMyNTAwOCZUcmFuc21pc3Npb25fSWQ9MjAyNjA0MDExNDA2UFJfTkVXU19VU1BSX19fX19EQzI1MDA4"/>

标普健康医疗设备 ETF - SPDR

标普全球医疗股指数 ETF - iShares

箭头制药

集体诉讼律师胡安·蒙特维尔德正在调查涉及 VYNE Therapeutics、麦斯莫医疗、独立银行公司和 HCB 金融公司的合并。VYNE 的股东将在与 Yarrow Bioscience 合并后拥有合并实体的 3% 股份。麦斯莫医疗的股东将从丹纳赫公司获得每股 180 美元。HCB 的股东将获得 1.5900 股独立银行股票以及每股 HCB 17.51 美元的现金。麦斯莫医疗的股东投票定于 2026 年 5 月 1 日。蒙特维尔德及其律师事务所在为股东追回资金方面有着良好的业绩记录

, /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde &amp; Associates PC (the &#34;M&amp;A Class Action Firm&#34;), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating
<div class="lb-trans">, /PRNewswire/ -- 集体诉讼律师 Juan Monteverde 与 Monteverde &amp; Associates PC（“M&amp;A 集体诉讼事务所”）为股东追回了数百万美元，并在 2025 年 ISS 证券集体诉讼服务报告中被认定为 前 50 名 事务所。我们总部位于 帝国大厦，位于纽约市，并正在调查
</div><ul>
<li>VYNE Therapeutics Inc. (NASDAQ: VYNE ) related to its merger with Yarrow Bioscience, Inc. Upon completion of the proposed transaction, VYNE shareholders are expected to own 3% of the combined company.</li>
</ul>
<div class="lb-trans"><ul>
<li>VYNE Therapeutics Inc. (NASDAQ: VYNE ) 与 Yarrow Bioscience, Inc. 的合并。完成拟议交易后，VYNE 股东预计将拥有合并公司 3% 的股份。</li>
</ul>
</div>Click here for more information https://monteverdelaw.com/case/vyne-therapeutics-inc/ . It is free and there is no cost or obligation to you.
<div class="lb-trans">点击此处获取更多信息 https://monteverdelaw.com/case/vyne-therapeutics-inc/ 。这是免费的，您无需支付任何费用或承担任何义务。
</div><ul>
<li>Masimo Corporation (NASDAQ: MASI ) r elated to its sale to Danaher Corporation. Under the terms of the proposed transaction, Masimo shareholders will receive $180.00 per share in cash.</li>
</ul>
<div class="lb-trans"><ul>
<li>Masimo Corporation (NASDAQ: MASI ) 与 Danaher Corporation 的出售相关。根据拟议交易的条款，Masimo 股东将获得每股 180.00 美元的现金。</li>
</ul>
</div>ACT NOW. The Shareholder Vote is scheduled for May 1, 2026.
<div class="lb-trans">立即行动。股东投票定于 2026 年 5 月 1 日。
</div>Click here for more information https://monteverdelaw.com/case/masimo-corporation/ . It is free and there is no cost or obligation to you.
<div class="lb-trans">点击此处获取更多信息 https://monteverdelaw.com/case/masimo-corporation/ 。这是免费的，您无需支付任何费用或承担任何义务。
</div><ul>
<li>Independent Bank Corporation (NASDAQ: IBCP ) related to its sale to HCB Financial Corp. Under the terms of the proposed transaction, HCB shareholders are expected to receive 1.5900 shares of Independent common stock and $17.51 for each share of HCB common stock.</li>
</ul>
<div class="lb-trans"><ul>
<li>Independent Bank Corporation (NASDAQ: IBCP ) 与 HCB Financial Corp. 的出售相关。根据拟议交易的条款，HCB 股东预计将获得 1.5900 股 Independent 普通股和每股 HCB 普通股 17.51 美元。</li>
</ul>
</div>Click here for more information https://monteverdelaw.com/case/independent-bank-corporation/ . It is free and there is no cost or obligation to you.
<div class="lb-trans">点击此处获取更多信息 https://monteverdelaw.com/case/independent-bank-corporation/ 。这是免费的，您无需支付任何费用或承担任何义务。
</div><ul>
<li>HCB Financial Corp. (OTCPK: HCBN ) related to its merger with Independent Bank Corporation. Under the terms of the proposed transaction, HCB shareholders are expected to receive 1.5900 shares of Independent common stock and $17.51 for each share of HCB common stock.</li>
</ul>
<div class="lb-trans"><ul>
<li>HCB Financial Corp. (OTCPK: HCBN ) 与 Independent Bank Corporation 的合并相关。根据拟议交易的条款，HCB 股东预计将获得 1.5900 股 Independent 普通股和每股 HCB 普通股 17.51 美元。</li>
</ul>
</div>Click here for more info https://monteverdelaw.com/case/hcb-financial-corp/ . It is free and there is no cost or obligation to you.
<div class="lb-trans">点击此处获取更多信息 https://monteverdelaw.com/case/hcb-financial-corp/ 。 这是免费的，您无需支付任何费用或承担任何义务。
</div>NOT ALL LAW FIRMS ARE THE SAME. Before you hire a law firm, you should talk to a lawyer and ask:
<div class="lb-trans">并非所有律师事务所都是一样的。 在您聘请律师事务所之前，您应该与律师交谈并询问：
</div><ol>
<li>Do you file class actions and go to Court?</li>
<li>When was the last time you recovered money for shareholders?</li>
<li>What cases did you recover money in and how much?</li>
</ol>
<div class="lb-trans"><ol>
<li>您是否提起集体诉讼并出庭？</li>
<li>您上次为股东追回资金是什么时候？</li>
<li>您在哪些案件中追回了资金，金额是多少？</li>
</ol>
</div>About Monteverde &amp; Associates PC
<div class="lb-trans">关于 Monteverde &amp; Associates PC
</div>Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court.
<div class="lb-trans">我们的事务所进行诉讼并为股东追回资金……我们在帝国大厦的办公室进行此项工作。我们是一家全国性的集体诉讼证券事务所，在审判和上诉法院，包括美国最高法院，拥有成功的业绩。
</div>No company, director or officer is above the law. If you own common stock in the above listed company and have concerns or wish to obtain additional information free of charge, please visit our website or contact Juan Monteverde, Esq. either via e-mail at [email protected] or by telephone at (212) 971-1341.
<div class="lb-trans">没有公司、董事或高管高于法律。 如果您拥有上述公司普通股并有疑虑或希望免费获取更多信息，请访问我们的 网站 或通过电子邮件联系 Juan Monteverde, Esq.，电子邮件地址为 [email protected] 或拨打电话 (212) 971-1341。
</div>Contact:
<div class="lb-trans">联系方式：
</div>Juan Monteverde, Esq.
<div class="lb-trans">Juan Monteverde, Esq.
</div>MONTEVERDE &amp; ASSOCIATES PC
<div class="lb-trans">MONTEVERDE &amp; ASSOCIATES PC
</div>The Empire State Building
<div class="lb-trans">帝国大厦
</div>350 Fifth Ave. Suite 4740
<div class="lb-trans">350 Fifth Ave. Suite 4740
</div>New York, NY 10118
<div class="lb-trans">New York, NY 10118
</div>United States of America
<div class="lb-trans">美国
</div>[email protected]
<div class="lb-trans">[email protected]
</div>Tel: (212) 971-1341
<div class="lb-trans">电话: (212) 971-1341
</div>Attorney Advertising. (C) 2026 Monteverde &amp; Associates PC. The law firm responsible for this advertisement is Monteverde &amp; Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.
<div class="lb-trans">律师广告。(C) 2026 Monteverde &amp; Associates PC。本广告的责任律师事务所为 Monteverde &amp; Associates PC (www.monteverdelaw.com)。之前的结果并不保证未来事务的类似结果。
</div>SOURCE Monteverde &amp; Associates PC
<div class="lb-trans">来源 Monteverde &amp; Associates PC
</div><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNDAxJk5ld3NJdGVtSWQ9REMyNTAwOCZUcmFuc21pc3Npb25fSWQ9MjAyNjA0MDExNDA2UFJfTkVXU19VU1BSX19fX19EQzI1MDA4" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=DC25008&amp;Transmission_Id=202604011406PR_NEWS_USPR_____DC25008&amp;DateId=20260401"/>

14:06 ETSHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--VYNE, MASI, IBCP, and HCBN

prnewswire

标普生物技术 3 倍做多 - Direxion

医疗业 ETF - SPDR

纽交所高增长板生物技术指数 ETF - First Trust

2 倍做多纳斯达克生物技术 ETF - ProShares

基因改革 ETF - ARK

麦斯莫医疗

纳斯达克生物科技指数 ETF - iShares Nasdaq

Invesco Nasdaq Biotechnology ETF

医药突破 ETF - ALPS

美国医药设备 ETF - iShares

14:06 股东警示：并购集体诉讼公司正在继续调查 VYNE、MASI、IBCP 和 HCBN 的合并事宜